Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2021 Aug 27;228:108985. doi: 10.1016/j.drugalcdep.2021.108985

Figure 3.

Figure 3.

Evaluation of zolpidem-induced sedative-motor effects (deep sedation, observable ataxia, rest/sleep posture) and changes in species-typical behavior (passive visual, tactile/oral exploration, self-groom) in rhesus monkeys (N=4) prior to chronic alprazolam treatment (“Pre-Chronic Alprazolam”) tests and after ≥14 days of 6 mg/kg/day alprazolam (“During Chronic Alprazolam”). Zolpidem is an α1GABAA-subtype-preferring positive modulator. Other details as described in the caption for Figure 1.